Leveraging linked open data by use of innovation leading technologies.

At Phenaris we constantly challenge the status quo in computational drug design and in silico toxicology.

Using cutting edge technologies we provide data, models, and decision support in all aspects of in silico toxicology. We are currently working on multiple solutions to provide data integration, model development, and decision support.

DATA INTEGRATION

In the era of big data, data curation and integration is an absolute requirement for approaching complex research questions. Being part of large scale, industry driven data integration initiatives, we offer our expertise in this area.

MODEL DEVELOPMENT

High quality predictive toxicity models are needed to support risk assessment. Based on high quality data, we provide a set of models for transporter and toxicity endpoints, which are constantly kept up to date.

DECISION SUPPORT

Prioritizing the right compounds is key for successful drug development. Our integrated toxicologcal read across platform supports decision making in all phases of drug discovery. This does not only save time and money, but also animal experiments.

For more information please visit our products and services pages.

Latest News

ToxPHACTS presented at life-science-success 2019

We are proud that ToxPHACTS was selected amongst the top 6 of the Science2Business Award 2019, which honors the best collaborations of science with business. This gave us the great opportunity to present our expert system for toxicological read across to a broad audience from science and economy at the[…]

Read more

ToxPHACTS Now Available Online

We are excited to announce that our basic version of ToxPHACTS is now available as a web service, free of charge for non-commercial use! This expert system for toxicological read across features user friendly tools to help scientists foresee possible toxicity of new development candidates, saving them not only time[…]

Read more

Phenaris Interview in Die Presse

The Austrian newspaper Die Presse has recently published an interview with us as one of the best participants in the i2b businessplan competition 2018: “Start-up-Steckbrief: Nebenwirkungen mittels Software erkennen. Hier stellen wir wieder einen der Besten des i2b Businessplan-Wettbewerbs vor: Phenaris. Als erstes Produkt entwickeln die Gründer ToxPHACTS, eine auf[…]

Read more

Subscribe

Sign up to recieve news and updates from Phenaris.